The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

With Isaac, US company PreEvnt has developed a non-invasive blood sugar monitoring device. The device was presented at CES ...

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

World Liberty Financial has filed for a US national banking charter as stablecoins shift from a trading tool into payment ...

A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...

A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its structurally diverse derivatives, highlighting how synthetic biology and metabolic ...

Materna Medical's Ellora Obstetrical System is designed to address a critical unmet need in labor and delivery--reducing pelvic floor injuries during vaginal birth. These injuries, often involving ...

PSMAddition is an international, open-label, prospective, phase 3 randomized controlled trial of 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC.

Europe needs a new system compelling researchers, governments and companies to share risk from the earliest stages of therapy ...

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...

DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...